Flinton Capital Management’s Novartis NVS Stock Holding History

Flinton Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.96M	Buy	22,512 +2,324	+12%	+$209K	0.06%	225
2019 Q2	$1.84M	Buy	20,188 +9,439	+88%	+$799K	0.06%	232
2019 Q1	$926K	Buy	10,749 +2,781	+35%	+$223K	0.03%	314
2018 Q4	$613K	Sell	7,968 -14,374	-64%	-$1.12M	0.02%	367
2018 Q3	$1.73M	Buy	22,342 +1,218	+6%	+$90K	0.05%	238
2018 Q2	$1.43M	Buy	21,124 +2,438	+13%	+$168K	0.05%	262
2018 Q1	$1.35M	Buy	18,686 +2,125	+13%	+$162K	0.05%	236
2017 Q4	$1.25M	Hold	16,561	–	–	0.04%	255
2017 Q3	$1.27M	Hold	16,561	–	–	0.05%	244
2017 Q2	$1.24M	Hold	16,561	–	–	0.05%	243
2017 Q1	$1.1M	Hold	16,561	–	–	0.04%	256
2016 Q4	$1.08M	Buy	+16,561	New	+$1.07M	0.05%	231

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Flinton Capital Management's NVS Position: Q3 2019 in Review

Flinton Capital Management increased its Novartis (NVS) stake by 12% in Q3 2019, buying an estimated $209K and bringing the position to 22,512 shares worth $1.96M. The position accounts for 0.06% of the portfolio, ranked #225.

Flinton Capital Management first reported a position in NVS in Q4 2016 and has held it in 12 quarters since. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Flinton Capital Management held 22,512 shares of Novartis worth $1.96M as of Q3 2019.
Flinton Capital Management bought 2,324 Novartis shares in Q3 2019, an estimated $209K.
Novartis made up 0.06% of Flinton Capital Management's portfolio in Q3 2019, its #225 holding.
Flinton Capital Management first reported a position in Novartis in Q4 2016 and has held it in 12 quarters since.
1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.